Comparison of potentiation of gastric mucus secretion between ranitidine and lafutidine-randamized cross-over trial

Trial Profile

Comparison of potentiation of gastric mucus secretion between ranitidine and lafutidine-randamized cross-over trial

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 23 Jun 2012

At a glance

  • Drugs Lafutidine (Primary) ; Ranitidine (Primary)
  • Indications Gastric ulcer; Gastritis; Peptic ulcer; Reflux oesophagitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 03 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top